文献速递流行病学与生物统计组学、生物样本库与精准医学

维生素D水平与哮喘、免疫球蛋白E升高及特应性皮炎易感性:一项孟德尔随机化研究

Vitamin D levels and susceptibility to asthma, elevated immunoglobulin E levels, and atopic dermatitis: A Mendelian randomization study.
PubMed 文献 · PLoS Med · 2017-05-09

该研究采用孟德尔随机化方法,利用英国生物银行及SUNLIGHT、GABRIEL和EAGLE湿疹联盟数据,以4个与25-羟基维生素D(25OHD)水平强相关的单核苷酸多态性(SNP)为工具变量,在33,996人中评估遗传性降低的25OHD对哮喘(n=146,761)、儿童期起病哮喘(n=15,008)、特应性皮炎(n=40,835)及免疫球蛋白E(IgE)升高(n=12,853)风险的影响。结果显示,遗传决定的25OHD水平降低与上述结局风险无显著关联,提示提高维生素D水平不太可能降低特应性疾病风险。

要点

  • 遗传性降低的25OHD水平与哮喘、特应性皮炎及IgE升高风险均无显著关联。
  • 每标准差log转换25OHD降低的孟德尔随机化OR:哮喘1.03,儿童期哮喘0.95,特应性皮炎1.12。
  • 对log转换IgE水平的效应量为-0.40,均无统计学显著性。

核心结论

  • 本研究未发现遗传决定的25OHD水平降低会增加哮喘、特应性皮炎或总血清IgE升高的风险,提示提高维生素D水平不太可能降低特应性疾病风险。

研究设计与样本

  • 采用孟德尔随机化方法,利用英国生物银行及SUNLIGHT、GABRIEL和EAGLE湿疹联盟数据,以4个与25OHD水平强相关的SNP为工具变量,在33,996人中评估遗传性降低的25OHD对哮喘(n=146,761)、儿童期起病哮喘(n=15,008)、特应性皮炎(n=40,835)及IgE升高(n=12,853)风险的影响。

主要发现

  • 4个降低25OHD的等位基因均与哮喘、特应性皮炎或IgE升高无关(p ≥ 0.2)。
  • 每标准差log转换25OHD降低的孟德尔随机化OR:哮喘1.03(95%CI 0.90-1.19,p=0.63),儿童期起病哮喘0.95(95%CI 0.69-1.31,p=0.76),特应性皮炎1.12(95%CI 0.92-1.37,p=0.27)。
  • 对log转换IgE水平的效应量为-0.40(95%CI -1.65至0.85,p=0.54)。
  • 上述结果在评估人群分层、多效性及维生素D合成与代谢通路的敏感性分析中持续存在。

局限性

  • 研究结果不能排除所研究结局与维生素D活性形式1,25-二羟维生素D之间的关联。
  • 研究对儿童期哮喘检测OR小于1.33的效应把握度不足。
  • 分析仅限于欧洲血统的白种人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low circulating vitamin D levels have been associated with risk of asthma, atopic dermatitis, and elevated total immunoglobulin E (IgE). These epidemiological associations, if true, would have public health importance, since vitamin D insufficiency is common and correctable. METHODS AND FINDINGS: We aimed to test whether genetically lowered vitamin D levels were associated with risk of asthma, atopic dermatitis, or elevated serum IgE levels, using Mendelian randomization (MR) methodology to control bias owing to confounding and reverse causation. The study employed data from the UK Biobank resource and from the SUNLIGHT, GABRIEL and EAGLE eczema consortia. Using four single-nucleotide polymorphisms (SNPs) strongly associated with 25-hydroxyvitamin D (25OHD) levels in 33,996 individuals, we conducted MR studies to estimate the effect of lowered 25OHD on the risk of asthma (n = 146,761), childhood onset asthma (n = 15,008), atopic dermatitis (n = 40,835), and elevated IgE level (n = 12,853) and tested MR assumptions in sensitivity analyses. None of the four 25OHD-lowering alleles were associated with asthma, atopic dermatitis, or elevated IgE levels (p ≥ 0.2). The MR odds ratio per standard deviation decrease in log-transformed 25OHD was 1.03 (95% confidence interval [CI] 0.90-1.19, p = 0.63) for asthma, 0.95 (95% CI 0.69-1.31, p = 0.76) for childhood-onset asthma, and 1.12 (95% CI 0.92-1.37, p = 0.27) for atopic dermatitis, and the effect size on log-transformed IgE levels was -0.40 (95% CI -1.65 to 0.85, p = 0.54). These results persisted in sensitivity analyses assessing population stratification and pleiotropy and vitamin D synthesis and metabolism pathways. The main limitations of this study are that the findings do not exclude an association between the studied outcomes and 1,25-dihydoxyvitamin D, the active form of vitamin D, the study was underpowered to detect effects smaller than an OR of 1.33 for childhood asthma, and the analyses were restricted to white populations of European ancestry. This research has been conducted using the UK Biobank Resource and data from the SUNLIGHT, GABRIEL and EAGLE Eczema consortia. CONCLUSIONS: In this study, we found no evidence that genetically determined reduction in 25OHD levels conferred an increased risk of asthma, atopic dermatitis, or elevated total serum IgE, suggesting that efforts to increase vitamin D are unlikely to reduce risks of atopic disease.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Manousaki D, Paternoster L, Standl M, et al. Vitamin D levels and susceptibility to asthma, elevated immunoglobulin E levels, and atopic dermatitis: A Mendelian randomization study. PLoS Med. 2017. PMID: 28486474. doi:10.1371/journal.pmed.1002294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。